Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.

Zhitongcaijing · 2d ago
Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.